Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3-day versus 7-day doxycycline for chlamydial infection
PACTR202401595629450Phase 4Not yet recruiting
- Sponsor
- Division of Microbiology and Infectious Diseases
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial of doxycycline in Chlamydia trachomatis infection (2 arms), sponsored by Division of Microbiology and Infectious Diseases. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
doxycycline
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on PACTR202401595629450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202401595629450.